Table 1 Sero-prevalence of CD in Asian-Pacific region among not at-risk population.

Tatar¹⁰

Turkey

Middle East

2001–2003

Adults

2000

33

t-TG^a,b

Moderate

22/1914 (1.1)

4/86 (0.2)

26/2000 (1.3)

Saberi-Firouzi¹¹

Iran

Middle East

2004

Adults

1440

45.5

t-TG^a

EMA^a

Low

–

–

7/1,440 (0.48)

Ertekin¹²

Turkey

Middle East

2005

Children

1263

11.9

t-TG^a

Moderate

6/687 (0.87)

5/576 (0.86)

11/1,263 (0.87)

Dalgic¹³

Turkey

Middle East

2006–2008

Children

20,190

11.6

t-TG^a

EMA^a,b

Moderate

213/10,368 (2.05)

276/9,822 (2.81)

489/20,190 (2.42)

Aljebreen¹⁴

Saudi Arabia

Middle East

2007–2008

Children

1167

16.6

EMA^a

Low

9/614 (1.46)

17/553 (3.07)

26/1,167 (2.2)

Abu-Zeid¹⁵

Arab Emirates

Middle East

2007–2008

Adults

1197

24.8

t-TG^a

EMA^a

Moderate

1/624 (0.16)

13/573 (2.27)

14/1,197 (1.17)

Makharia¹⁶

India

South Asia

2008–2009

*both

10,488

22.45

t-TG^a

Moderate

68/5305 (1.28)

83/5183 (1.60)

151/10,488 (1.44)

Makharia¹⁶

India

South Asia

2008–2009

Adults

6845

34.4

t-TG^a

Moderate

–

–

75/6,845 (1.10)

Makharia¹⁶

India

South Asia

2008–2009

Children

3643

10.5

t-TG^a

Moderate

–

–

76/3,643 (2.06)

Yuan¹⁷

China

East Asia

2010–2013

Young Adults

19,778

18.8

t-TG^a

DGP^b

Moderate

2/13,322 (0.01)

9/6,456 (0.14)

11/19,778 (0.06)

Sezgin¹⁸

Turkey

Middle East

2011–2013

Adults

1554

42.1

t-TG^a,b

DGP^a,b

Moderate

2/772 (0.12)

10/782 (0.64)

12/1554 (0.77)

Ramakrishna¹⁹

India

South Asia

2011–2013

Adults

23,331

35

t-TG^a

Low

58/10,776 (0.5)

100/12,555 (0.8)

158/23,331 (0.68)

Dehghani²⁰

Iran

Middle East

2013

Children

1500

9.5

t-TG^a

Low

–

–

30/1500 (2)

Hatlani²¹

Saudi Arabia

Middle East

2012–2014

Children

1141

11

t-TG^a

Moderate

12/454 (2.6)

20/687 (3)

32/1,141 (2.8)

Yap²²

Malaysia

South Asia

2012–2014

Adults

562

24

AGA^a,b

t-TG^a,b

EMA^a,b

Moderate

1/238 (0.4)

6/324 (1.9)

7/562 (1.25)